SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P50
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | -32.00% |
| 2024 | -36.79% |
| 2023 | 1.21% |
| 2022 | -186.11% |
| 2021 | -228.46% |
| 2020 | 72.24% |
| 2019 | 0.00% |